Rationale Behind the Clinical Development of Combination Immunotherapy for Pancreatic Cancer
Part of the Surgical Grand Rounds Series - Lei Zheng, Md, PhD, discusses immunotherapy in pancreatic cancer, focuses on attacking T Cells, and reviews effective treatment options.
Created by
Related Presenters
Associate Professor of Oncology
Expertise Anal Cancer, Bile Duct Cancer, Carcinoid Syndrome, Carcinoid Tumors, Cholangiocarcinoma, Colon Cancer, Colorectal Cancer, Gastric Cancer, Gastroesophageal Junction Cancer, Gastrointestinal Cancers, Gastrointestinal Tumors, Hepatocellular ...
Facebook
Twitter
YouTube